Improvement of Sickle Cell Disease Morbimortality in Children: Experience in a Remote Area of an African Country
Preprint
- 19 October 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: Sickle cell disease (SCD) is a public health problem in the Democratic Republic of Congo. While reference sickle cell centers have been implemented in capital cities of African countries and have proven to be beneficial for SCD patients, they have never been set up in rural areas for families with very low sources of income. Method: A cohort of 143 children with SCD aged 10 years old (IQR (interquartile range): 6–15 years) (sex ratio male/female = 1.3) were clinically followed for 12 months without any specific intervention aside from the management of acute events, and then for 12 months with a monthly medical visit, biological follow-up, and regular prophylaxis. Results: The median age of patients at the diagnosis of SCD was 2 years (IQR: 1–5). The implementation of standardized and regular follow-ups in a new sickle cell referral center in a remote city showed an increase in the annual mean hemoglobin level from 50 to 70 g/L (p = 0.001), and a decrease in the lymphocyte count and spleen size (p < 0.001). A significant decrease (p < 0.001) in the average annual number of hospitalizations and episodes of vaso-occlusive crises, blood transfusions, infections, and acute chest syndromes were also observed. Conclusions: Creation of a sickle cell referral center and the regular follow-up of children with SCD are possible and applicable in the context of a remote city of an African country and represent simple and accessible measures that can reduce the morbimortality of children with sickle cell disease.Keywords
All Related Versions
This publication has 42 references indexed in Scilit:
- Prospective longitudinal follow‐up of children with sickle cell disease treated with hydroxyurea since infancyPediatric Blood & Cancer, 2019
- Hydroxyurea — An Essential Medicine for Sickle Cell Disease in AfricaNew England Journal of Medicine, 2019
- Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan AfricaNew England Journal of Medicine, 2019
- Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub‐Saharan AfricaAmerican Journal of Hematology, 2018
- The clinical epidemiology of sickle cell anemia In AfricaAmerican Journal of Hematology, 2017
- Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatmentPediatric Blood & Cancer, 2015
- Sickle cell disease among children in Africa: An integrative literature review and global recommendationsInternational Journal of Africa Nursing Sciences, 2015
- Hydroxyurea for the treatment of sickle cell disease: Efficacy, barriers, toxicity, and management in childrenPediatric Blood & Cancer, 2012
- Management of Sickle Cell Disease; Lessons from the Jamaican Cohort StudyBlood Reviews, 1993
- Prophylaxis with Oral Penicillin in Children with Sickle Cell AnemiaNew England Journal of Medicine, 1986